I'm reflecting on the recent adjustment of NICE thresholds to £25,000 to £35,000 per quality-adjusted life year (QALY). What should be the main focus to ensure these changes effectively enhance medicine access? Share your insights by voting below!
What should be the primary focus to ensure the success of the new NICE thresholds?